
    
      A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate
      the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal
      Spray 100mcg for 2 Weeks in Adult and Adolescent Subjects (12 years of age and older) with
      Seasonal Allergic Rhinitis (SAR)
    
  